Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI110439

Functionally Abnormal Na+-K+ Pump in Erythrocytes of a Morbidly Obese Patient

Mario Deluise and Jeffrey S. Flier

Charles A. Dana Research Institute, and the Harvard-Thorndike Laboratory of Beth Israel Hospital, Boston, Massachusetts 02215

Department of Medicine, Beth Israel Hospital, Boston, Massachusetts 02215

Harvard Medical School, Boston, Massachusetts 02215

Find articles by Deluise, M. in: PubMed | Google Scholar

Charles A. Dana Research Institute, and the Harvard-Thorndike Laboratory of Beth Israel Hospital, Boston, Massachusetts 02215

Department of Medicine, Beth Israel Hospital, Boston, Massachusetts 02215

Harvard Medical School, Boston, Massachusetts 02215

Find articles by Flier, J. in: PubMed | Google Scholar

Published January 1, 1982 - More info

Published in Volume 69, Issue 1 on January 1, 1982
J Clin Invest. 1982;69(1):38–44. https://doi.org/10.1172/JCI110439.
© 1982 The American Society for Clinical Investigation
Published January 1, 1982 - Version history
View PDF
Abstract

The Na+-K+ pump in the erythrocytes of a mordibly obese patient shows a unique constellation of functional abnormalities. The number of pump units, measured by [3H]ouabain binding to intact cells, as well as the enzymatic activity of the (Na+-K+)-dependent ATPase in erythrocyte membranes were found to be markedly increased compared with control cells (18-fold and 14-fold, respectively). There was a concomitant fivefold increase in the rate of pump-mediated uptake of 86Rubidium (a K analogue); this was balanced by an increased rate of 86Rb efflux. In striking contrast to normal cells, however, a major portion of this efflux (80%) was inhibited by ouabain, and thus appeared to be mediated by the Na+-K+ pump.

Erythrocytes from this patient had elevated levels of intracellular K+ and reduced levels of intracellular Na+. This finding, taken together with the ouabain inhibition of K+ efflux and the absence of associated abnormalities, argues against the possibility that the increased number of Na+-K+ pump units was a compensation for a primary increase in the permeability of the erythrocyte membrane to monovalent cations, as is seen in a variety of erythrocyte disorders. Further evidence for a primary abnormality of the enzyme was our observation that the cardiac glycoside ouabain bound to these cells with reduced affinity and had a right shifted dose response for pump inhibition. The markedly increased number of Na+-K+ pump units in these cells did not appear to extend to mononuclear leukocytes.

In conclusion, the erythrocytes from this patient have a very large number of functionally abnormal Na+-K+ ATPase units. A unique abnormality of the erythrocyte Na+-K+ ATPase of these cells is the most likely explanation for these findings.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 38
page 38
icon of scanned page 39
page 39
icon of scanned page 40
page 40
icon of scanned page 41
page 41
icon of scanned page 42
page 42
icon of scanned page 43
page 43
icon of scanned page 44
page 44
Version history
  • Version 1 (January 1, 1982): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts